The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
_256_384.jpg)
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
A brand from Opella will be part of the official NASA astronaut formulary
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
Subscribe To Our Newsletter & Stay Updated
